Skip to main content

Page of 2 next disabled
and
  1. No Access

    Chapter

    Surgical Management of Glial Cancers

    The value of surgery for low- and high-grade gliomas alike has long been debated due to the lack of randomized controlled data. Recent studies are providing more and more insight into different benefits derive...

    Walter Stummer in Emerging Concepts in Neuro-Oncology (2013)

  2. No Access

    Article

    Lack of MGMT promoter hypermethylation in hemangiopericytomas of the central nervous system

    Benjamin Brokinkel, Susanne Peetz-Dienhart, Kathy Keyvani in Journal of Neuro-Oncology (2012)

  3. Article

    Open Access

    Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery

    Survival of glioblastoma patients has been linked to the completeness of surgical resection. Available data, however, were generated with adjuvant radiotherapy. Data confirming that extensive cytoreduction rem...

    Walter Stummer, Thomas Meinel, Christian Ewelt, Peter Martus in Journal of Neuro-Oncology (2012)

  4. No Access

    Article

    Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival

    According to recent developments the best treatment options for glioblastoma (GBM) consist in maximum safe resection and additional adjuvant treatment with radiotherapy (RT) and alkylating chemotherapy (CHX)....

    Christian Ewelt, Mathias Goeppert, Marion Rapp in Journal of Neuro-Oncology (2011)

  5. No Access

    Article

    Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA

    The primary objective of this augmental, prospective, uncontrolled phase II multicentre trial was to assess adverse events (AE) associated with malignant glioma resection using 5-aminolevulinic (5-ALA). During...

    Walter Stummer, Ulf Nestler, Florian Stockhammer, Dietmar Krex in Journal of Neuro-Oncology (2011)

  6. No Access

    Article

    MGMT promoter methylation status in anaplastic meningiomas

    Benjamin Brokinkel, Bernhard R. Fischer in Journal of Neuro-Oncology (2010)

  7. No Access

    Article

    Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report

    Glioblastoma multiforme continues to be a devastating disease despite modest improvements in survival achieved at present, and there is an urgent need for innovative treatment concepts. Five-aminolevulinic aci...

    Walter Stummer, Tobias Beck, Wolfgang Beyer in Journal of Neuro-Oncology (2008)

  8. No Access

    Article

    Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model

    Aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) may represent a treatment option for malignant brain tumors. We used a three-dimensional cell culture system, the C6 glioma spheroid model, to stud...

    Pitr Zelenkov, Reinhold Baumgartner, Karl Bise, Michael Heide in Journal of Neuro-Oncology (2007)

Page of 2 next disabled